Showing results (701-710 of 993) with videos related to
Sort By:
Pageof 100
The Science of the Total Environment|September 1, 2018
Seasonal variability in vulnerability for Cassin's auklets (Ptychoramphus aleuticus) exposed to microplastic pollution in the Canadian Pacific regionPatrick D O'Hara, Stephanie Avery-Gomm, Jocelyn Wood, et al.International Journal of Computer Assisted Radiology and Surgery|October 26, 2021
Quantification of pulmonary involvement in COVID-19 pneumonia by means of a cascade of two U-nets: training and assessment on multiple datasets using different annotation criteriaFrancesca Lizzi, Abramo Agosti, Francesca Brero, et al.Brain Research|May 23, 2015
Experimental evidence that bioenergetics disruption is not mainly involved in the brain injury of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overloadAlexandre Umpierrez Amaral, Cristiane Cecatto, Bianca Seminotti, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 1, 2019
Dietary calcium intake and adiposity in children and adolescents: Cross-sectional and longitudinal results from IDEFICS/I.Family cohortA Nappo, S Sparano, T Intemann, et al.Journal of Biological Response Modifiers|December 1, 1990
A phase I study of high-dose interleukin-2 in combination with interferon-alpha 2bM Sznol, J W Mier, J Sparano, et al.Journal of the Endocrine Society|November 18, 2022
Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor SizeClotilde Sparano, Mario Rotondi, Valentina Verdiani, et al.Cancer Chemotherapy and Pharmacology|February 15, 2020
Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-upBhavana Pothuri, Allison L Brodsky, Joseph A Sparano, et al.Cancer|June 22, 2010
Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapyMary Cianfrocca, Sandra Lee, Jamie Von Roenn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapyHenri Roché, Louise Yelle, Francesco Cognetti, et al.Cancers|April 5, 2020
Validation of an Automated Quantitative Digital Pathology Approach for Scoring TMEM, a Prognostic Biomarker for MetastasisDavid Entenberg, Maja H Oktay, Timothy D'Alfonso, et al.Pageof 100